The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a virulence gene, i.e. a gene that makes the virus harmful to humans, the herpes ...

Unlisted biotech firm IDT Biologika has won approval from Germany's vaccine regulator to become the third German company after BioNTech and CureVac to launch human trials of an experimental ...

Company Underscores Rigorous Safety Monitoring and Long History of the MVA Platform as Development of GEO-CM04S1 Advances ATLANTA, GA - September 22, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: ...

The world's first vaccine trial against elephant endotheliotropic herpesvirus (EEHV)—a leading cause of death in young Asian elephants—is safe and triggers a strong virus-fighting immune response, ...

Viral Sensitizers Market: Viral Vaccines Market Segment to hold the Largest Market Share in 2023 Given the increasing demand for viral vaccines and the growing world population, the viral sensitizers ...

Next-generation vaccines enhance immunization with precision-targeted immune responses, transforming public health and addressing global health challenges.

Newcastle disease (ND) is a highly contagious viral disease of poultry with global economic significance. Caused by avian ...

Germany awarded $745 million in funding to biotech firms BioNTech and CureVac on Tuesday to speed up work on COVID-19 vaccines and expand German production capacity.

Emerging opportunities in the viral vector manufacturing market include personalized medicine growth, expanded clinical trials, and regional manufacturing partnerships. Advances in bioprocessing and ...

Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...